首页|NT-pro BNP、Hcy及Apo-A与急性心肌梗死患者心力衰竭程度及预后的相关性

NT-pro BNP、Hcy及Apo-A与急性心肌梗死患者心力衰竭程度及预后的相关性

扫码查看
目的:探究N-末端脑钠肽前体(NT-pro BNP)、同型半胱氨酸(Hcy)及载脂蛋白A(Apo-A)与急性心肌梗死(AMI)患者心力衰竭(HF)程度及预后的相关性.方法:选择我院2021年1月至2023年12月收治的100例AMI患者作为研究对象,按有无合并HF设为HF组(n=44)与非HF组(n=56).检测全部患者血清NT-pro BNP、Hcy及Apo-A水平,以Killip 分级评估HF组患者HF程度,将HF组患者按预后情况分为预后良好组(n=24)与预后不良组(n=20).采用单因素及多因素分析影响AMI患者预后不良的因素,并采用受试者工作曲线(ROC)分析血清NT-pro BNP、Hcy及Apo-A水平预测AMI合并HF患者预后的价值.结果:HF组患者血清NT-pro BNP、Hcy及Apo-A水平高于非HF组(P<0.05).HF Ⅳ级组患者血清NT-pro BNP、Hcy及Apo-A水平高于Ⅲ级组、Ⅱ级组,且Ⅲ级组高于Ⅱ级组(P<0.05).经Spearson相关性分析显示,血清NT-pro BNP、Hcy及Apo-A水平与HF程度均呈正相关(r=0.612、0.505、0.649,P<0.05).预后良好组与预后不良组患者年龄、高脂血症史、心界扩大、NT-pro BNP、Hcy及Apo-A水平比较,差异有统计学意义(P<0.05).Logistic回归分析显示,年龄、NT-pro BNP、Hcy及Apo-A为AMI合并HF患者预后的影响因素(P<0.05).血清NT-pro BNP水平预测水平AMI合并HF患者预后的AUC为0.769(0.617~0.882),灵敏度75.00%,特异度79.17%(P<0.05);血清Hcy水平预测AMI合并HF患者预后的AUC为0.833(0.690~0.928),灵敏度95.00%,特异度58.33%(P<0.05);血清Apo-A水平预测AMI合并HF患者预后的AUC为0.877(0.743~0.957),灵敏度85.00%,特异度91.67%(P<0.05).结论:血清NT-pro BNP、Hcy及Apo-A水平随AMI患者HF级别递增而上升,且与患者预后密切相关,具有较高预测价值.
Correlation of NT-pro BNP,Hcy and Apo-A with Heart Failure Degree and Prognosis in Patients with Acute Myocardial Infarction
Objective:To investigate the correlation between N-terminal pro-brain natriuretic peptide(NT-pro BNP),homocysteine(Hcy)and apolipoprotein A(Apo-A)and the heart failure(HF)degree and prognosis in patients with acute myocardial infarction(AMI).Methods:100 patients with AMI admitted to our hospital from January 2021 to December 2023 were selected as the research objects,and were divided into the HF group(n=44)and the non-HF group(n=56)according to whether they had HF.Serum NT-pro BNP,Hcy and Apo-A levels of all patients were detected,and the HF degree of patients in the HF group was evaluated by Killip grad-ing.Patients in the HF group were divided into good prognosis group(n=24)and poor prognosis group(n=20)according to the progno-sis.The influencing factors of poor prognosis of AMI patients were analyzed by univariate and multifactorial analysis,and the receiver operating curve(ROC)was used to analyze the prognostic value of serum NT-pro BNP,Hcy and Apo-A levels in patients with AMI com-bined with HF.Results:The levels of serum NT-pro BNP,Hcy and Apo-A of patients in the HF group were higher than those in non-HF group(P<0.05).The levels of serum NT-pro BNP,Hcy and Apo-A of patients in HF grade Ⅳ group were higher than those in gradeⅢ and grade Ⅱ groups,and the levels of serum NT-pro BNP,Hcy and Apo-A of patients in HF grade Ⅲ group were higher than those in grade Ⅱ group(P<0.05).Spearson correlation analysis showed that serum NT-pro BNP,Hcy and Apo-A levels were positively corre-lated with HF degrees(r=0.612,0.505,0.649,P<0.05).There were statistically significant differences in age,history of hyperlipid-emia,cardiac enlargement,NT-pro BNP,Hcy and Apo-A levels between the two groups of patients(P<0.05).Logistic regression analysis showed that age,NT-pro BNP,Hcy and Apo-A levels were the prognostic factors of AMI patients with HF(P<0.05).The AUC of serum NT-pro BNP level in predicting prognosis of AMI patients with HF was 0.769(0.617-0.882),the sensitivity was 75.00%,and the specificity was 79.17%(P<0.05).The AUC of serum Hcy level in predicting prognosis of AMI patients with HF was 0.833(0.690~0.928),the sensitivity was 95.00%,and the specificity was 58.33%(P<0.05).The AUC of serum Apo-A level in pre-dicting prognosis of AMI patients with HF was 0.877(0.743-0.957),the sensitivity was 85.00%,and the specificity was 91.67%(P<0.05).Conclusion:Serum NT-pro BNP,Hcy and Apo-A levels increase with the increase of the degree of HF in AMI patients,which are closely related to the prognosis of AMI patients with HF and have high predictive value.

Acute myocardial infarctionHeart failureN-terminal pro-brain natriuretic peptideHomocysteineApolipoprotein A

王璐、金烨、陈奕纬

展开 >

上海交通大学医学院附属第九人民医院黄浦分院急诊科,上海 200011

上海交通大学医学院附属第九人民医院黄浦分院心内科,上海 200011

急性心肌梗死 心力衰竭 N-末端脑钠肽前体 同型半胱氨酸 载脂蛋白A

2024

中国医药导刊
国家食品药品监督管理局信息中心

中国医药导刊

影响因子:1.408
ISSN:1009-0959
年,卷(期):2024.26(4)
  • 8